Filter results
Type
Audience
Last updated
Topics
-
Literature review of international biosimilar medicines update – September to December 2016
Resources › Publications13 April 2017 - This reports updates a literature review that looked at international and Australian clinical, academic and policy journals, as well as media articles or sources in relation to biosimilar medicines, to help inform policy development and communication activities. It covers September to December 2016.
-
Literature review of international biosimilar medicines update – March to May 2017
Resources › Publications16 October 2017 - This reports updates a literature review that looked at international and Australian clinical, academic and policy journals, as well as media articles or sources in relation to biosimilar medicines, to help inform policy development and communication activities. It covers March to May 2017.
-
Literature review of international biosimilar medicines update – June to August 2017
Resources › Publications20 September 2017 - This reports updates a literature review that looked at international and Australian clinical, academic and policy journals, as well as media articles or sources in relation to biosimilar medicines, to help inform policy development and communication activities. It covers June to August 2017.
-
Literature review of international biosimilar medicines update – September to November 2017
Resources › Publications29 January 2018 - This reports updates a literature review that looked at international and Australian clinical, academic and policy journals, as well as media articles or sources in relation to biosimilar medicines, to help inform policy development and communication activities. It covers September to November 2017.
-
Literature review of international biosimilar medicines update – March to May 2018
Resources › Publications17 July 2018 - This reports updates a literature review that looked at international and Australian clinical, academic and policy journals, as well as media articles or sources in relation to biosimilar medicines, to help inform policy development and communication activities. It covers March to May 2018.
-
SPAP public summary documents – April 2020 – Omnigon Flexima Active
Resources › Publications2 June 2020 - This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to delete 5 variants that are no longer available in the current listing of the Omnigon Flexima Active from subgroup 1(b) of the Stoma Appliance Scheme Schedule.
-
Recommendations on Adult Haemopoietic Progenitor Cell Donor Recruitment Reform
Resources › Publications18 December 2023 - The recommendations provided in this report reference point-in-time data and current service providers involved in HPC donor recruitment. These recommendations are being considered by all governments, and where supported, will be prioritised according to need and available resources.
-
COVID-19 Vaccine Claims Scheme – Guidance for injuries caused by vaccine administration
Resources › Publications19 December 2023 - This document sets out points to consider for doctors providing clinical opinion in support of COVID-19 vaccine injury claims following vaccination with a TGA approved vaccine.
-
Australian Health Protection Principal Committee (AHPPC) statement on mandatory vaccination of all workers in health care settings
News and media1 October 2021 - A statement from the Australian Health Protection Principal Committee (AHPPC) on National Principles for Infection Prevention and Control in Quarantine.
-
General Practice in Aged Care Incentive – Vodcast 4 – Facilitators and enablers
Resources › Videos24 March 2025 - The General Practice in Aged Care Incentive will make it easier for older people living in residential aged care homes to receive regular visits and care planning services from their responsible GP and practice.